Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03582722 · ClinicalTrials.gov registry record · Phase 4
Weight Loss Aid in an Exposed Population
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT03582722 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 100 participants.
The verdict
NCT03582722, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).
Interventions
- DIETARY_SUPPLEMENT Multivitamin
- DRUG Orlistat
- DRUG Placebo capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03582722
The ClinicalTrials.gov registry entry for NCT03582722 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Multivitamin is the first listed.
NCT03582722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03582722 about?
NCT03582722 is a clinical study titled "Weight Loss Aid in an Exposed Population". This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).
What is the current status of trial NCT03582722?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-09-14. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03582722?
The interventions under investigation include: Multivitamin (DIETARY_SUPPLEMENT), Orlistat (DRUG), Placebo capsule (DRUG).
Who is sponsoring clinical trial NCT03582722?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.